M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytes
- PMID: 28874845
- PMCID: PMC5585332
- DOI: 10.1038/s41598-017-11303-z
M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytes
Abstract
Acute injury in the setting of liver fibrosis is an interesting and still unsettled issue. Most recently, several prominent studies have indicated the favourable effects of liver fibrosis against acute insults. Nevertheless, the underlying mechanisms governing this hepatoprotection remain obscure. In the present study, we hypothesized that macrophages and their M1/M2 activation critically involve in the hepatoprotection conferred by liver fibrosis. Our findings demonstrated that liver fibrosis manifested a beneficial role for host survival and apoptosis resistance. Hepatoprotection in the fibrotic liver was tightly related to innate immune tolerance. Macrophages undertook crucial but divergent roles in homeostasis and fibrosis: depleting macrophages in control mice protected from acute insult; conversely, depleting macrophages in fibrotic liver weakened the hepatoprotection and gave rise to exacerbated liver injury upon insult. The contradictory effects of macrophages can be ascribed, to a great extent, to the heterogeneity in macrophage activation. Macrophages in fibrotic mice exhibited M2-preponderant activation, which was not the case in acutely injured liver. Adoptive transfer of M2-like macrophages conferred control mice conspicuous protection against insult. In vitro, M2-polarized macrophages protected hepatocytes against apoptosis. Together, M2-like macrophages in fibrotic liver exert the protective effects against lethal insults through conferring apoptosis resistance to hepatocytes.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in ACLF by inhibiting pyroptosis but not necroptosis signalling.Cell Death Dis. 2022 Sep 8;13(9):775. doi: 10.1038/s41419-022-05181-1. Cell Death Dis. 2022. PMID: 36075893 Free PMC article.
-
Cellular Mechanisms of Hepatoprotection Mediated by M2-Like Macrophages.Med Sci Monit. 2018 Apr 30;24:2675-2682. doi: 10.12659/MSM.907222. Med Sci Monit. 2018. PMID: 29708961 Free PMC article.
-
M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis.Cell Death Dis. 2021 Jan 18;12(1):93. doi: 10.1038/s41419-020-03378-w. Cell Death Dis. 2021. PMID: 33462187 Free PMC article.
-
Macrophage Phenotype in Liver Injury and Repair.Scand J Immunol. 2017 Mar;85(3):166-174. doi: 10.1111/sji.12468. Scand J Immunol. 2017. PMID: 27491503 Review.
-
Monocytes and macrophages as cellular targets in liver fibrosis.Inflamm Allergy Drug Targets. 2009 Sep;8(4):307-18. doi: 10.2174/187152809789352230. Inflamm Allergy Drug Targets. 2009. PMID: 19534673 Review.
Cited by
-
TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation.Stem Cell Res Ther. 2024 Feb 16;15(1):44. doi: 10.1186/s13287-024-03648-w. Stem Cell Res Ther. 2024. PMID: 38360740 Free PMC article.
-
Sappanone A Alleviates the Severity of Carbon Tetrachloride-Induced Liver Fibrosis in Mice.Antioxidants (Basel). 2023 Sep 4;12(9):1718. doi: 10.3390/antiox12091718. Antioxidants (Basel). 2023. PMID: 37760020 Free PMC article.
-
Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease.Stem Cells Int. 2023 Jan 6;2023:3919002. doi: 10.1155/2023/3919002. eCollection 2023. Stem Cells Int. 2023. PMID: 36644008 Free PMC article. Review.
-
17α-estradiol, a lifespan-extending compound, attenuates liver fibrosis by modulating collagen turnover rates in male mice.Am J Physiol Endocrinol Metab. 2023 Feb 1;324(2):E120-E134. doi: 10.1152/ajpendo.00256.2022. Epub 2022 Dec 14. Am J Physiol Endocrinol Metab. 2023. PMID: 36516471 Free PMC article.
-
Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in ACLF by inhibiting pyroptosis but not necroptosis signalling.Cell Death Dis. 2022 Sep 8;13(9):775. doi: 10.1038/s41419-022-05181-1. Cell Death Dis. 2022. PMID: 36075893 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
